{"pmid": "12626215", "sentences": {"sent_1": {"Section": "", "text": "METHODS : A letter of invitation to participate in the study was mailed to women who had undergone hysterectomy and bilateral oophorectomy for benign disorders during 1990 - 98 .", "entities": {"entity_1": {"text": "women", "class": "Participant", "negation": 0, "UMLS": "", "index": 1, "start": 14}, "entity_2": {"text": "undergone hysterectomy", "class": "Participant", "negation": 0, "UMLS": "C0020699:hysterectomy,", "index": 2, "start": 17}, "entity_3": {"text": "bilateral oophorectomy", "class": "Participant", "negation": 0, "UMLS": "C0278321:bilateral oophorectomy,", "index": 3, "start": 20}, "entity_4": {"text": "benign disorders", "class": "Participant", "negation": 0, "UMLS": "C0012634:disorders,", "index": 4, "start": 23}, "attribute_1": {"text": "1990 - 98", "class": "measure", "negation": 0, "UMLS": "", "index": 5, "start": 26}}, "relations": {}}, "sent_2": {"Section": "", "text": "Fifty women , 45 - 60 years old , were consecutively recruited and randomly assigned to oral treatment with testosterone undecanoate 40 mg plus estradiol valerate 2 mg daily or placebo plus estradiol valerate 2 mg daily for 24 weeks .", "entities": {"entity_5": {"text": "women", "class": "Participant", "negation": 0, "UMLS": "", "index": 1, "start": 1}, "attribute_2": {"text": "45 - 60 years", "class": "measure", "negation": 0, "UMLS": "", "index": 2, "start": 3}, "entity_6": {"text": "testosterone undecanoate 40 mg plus estradiol valerate 2 mg daily", "class": "Intervention", "negation": 0, "UMLS": "C0076195:testosterone undecanoate,C0059623:estradiol valerate,", "index": 3, "start": 19}, "attribute_3": {"text": "40 mg plus estradiol valerate 2 mg daily", "class": "measure", "negation": 0, "UMLS": "C0059623:estradiol valerate,", "index": 4, "start": 21}, "attribute_4": {"text": "2 mg daily", "class": "measure", "negation": 0, "UMLS": "", "index": 5, "start": 26}, "entity_7": {"text": "placebo", "class": "Intervention", "negation": 0, "UMLS": "C0032042:placebo,", "index": 6, "start": 30}, "entity_8": {"text": "estradiol valerate 2 mg daily", "class": "Intervention", "negation": 0, "UMLS": "C0059623:estradiol valerate,", "index": 7, "start": 32}, "attribute_5": {"text": "2 mg daily", "class": "measure", "negation": 0, "UMLS": "", "index": 8, "start": 34}}, "relations": {}}, "sent_3": {"Section": "", "text": "A double - blind design was chosen , with cross-over to the other regimen for another 24 weeks of treatment .", "entities": {}, "relations": {}}, "sent_4": {"Section": "", "text": "Forty - four women completed the study .", "entities": {"entity_9": {"text": "women", "class": "Participant", "negation": 0, "UMLS": "", "index": 1, "start": 3}}, "relations": {}}, "sent_5": {"Section": "", "text": "Outcome included scores on McCoy 's sex scale questionnaire , the Psychological General Well - Being index and a self - esteem questionnaire , at baseline and after 24 weeks of either treatment .", "entities": {"entity_10": {"text": "McCoy 's sex scale questionnaire", "class": "Outcome", "negation": 0, "UMLS": "C0034394:questionnaire,C0175659:scale,C0009253:sex,", "index": 1, "start": 4}, "entity_11": {"text": "Psychological General Well - Being index", "class": "Outcome", "negation": 0, "UMLS": "C3812897:General,C0918012:index,C1306597:psychological,", "index": 2, "start": 11}, "entity_12": {"text": "self - esteem questionnaire", "class": "Outcome", "negation": 0, "UMLS": "C0034394:questionnaire,C1551994:self,", "index": 3, "start": 19}}, "relations": {}}, "sent_6": {"Section": "", "text": "Serum concentrations of total testosterone , sex hormone binding globulin , free testosterone , dihydrotestosterone , androstenedione , estradiol , follicle stimulating hormone and luteinizing hormone were analyzed at baseline and after 24 weeks of both treatment regimens .", "entities": {"entity_13": {"text": "Serum concentrations of total testosterone", "class": "Outcome", "negation": 0, "UMLS": "C0086045:concentrations,C0039601:testosterone,C0229671:Serum,", "index": 1, "start": 0}, "entity_14": {"text": "sex hormone binding globulin", "class": "Outcome", "negation": 0, "UMLS": "C0036884:sex hormone,", "index": 2, "start": 6}, "entity_15": {"text": "free testosterone", "class": "Outcome", "negation": 0, "UMLS": "C0039601:testosterone,", "index": 3, "start": 11}, "entity_16": {"text": "dihydrotestosterone", "class": "Outcome", "negation": 0, "UMLS": "C0038148:dihydrotestosterone,", "index": 4, "start": 14}, "entity_17": {"text": "androstenedione", "class": "Outcome", "negation": 0, "UMLS": "C0002860:androstenedione,", "index": 5, "start": 16}, "entity_18": {"text": "estradiol", "class": "Outcome", "negation": 0, "UMLS": "C0014912:estradiol,", "index": 6, "start": 18}, "entity_19": {"text": "follicle stimulating hormone", "class": "Outcome", "negation": 0, "UMLS": "C0733758:follicle stimulating hormone,", "index": 7, "start": 20}, "entity_20": {"text": "luteinizing hormone", "class": "Outcome", "negation": 0, "UMLS": "C0023607:luteinizing hormone,", "index": 8, "start": 24}}, "relations": {}}}}